Imagine this scenario – You’ve developed a promising formulation—maybe it’s a new dosage form, or perhaps a niche indication—but setting up a full scale manufacturing plant in India will cost you years, significant capital, and operational risk. Meanwhile, your competitor might already be launching similar products. That is where third-party pharma manufacturing becomes a strategic option.
